To further explore the association between CCZ1 expression and the prognosis of CSCC patients, we stratified 239 CSCC patients into two groups, 62 patients with high CCZ1 expression and 167 patients with low CCZ1 expression, based on median CCZ1 expression. The gene discussed is CCZ1; the disease is skin squamous cell carcinoma.